EUVIMEDEUVIMED entdecken
Crossref

Magnolol ameliorates Streptococcus suis serotype 2-induced pulmonary inflammatory injury in mice via inhibition of GSDMD

Jiedan Liao, Yixin Xiu, Rouna Su, Zhaoru Wu, Ziteng Deng, Honglin Xie, Xiaoshu Zhan, Yajuan Li, Qinqin Sun, Yunfei Huang, Qiang Fu

Microbial Pathogenesis · 2026

DOI: 10.1016/j.micpath.2026.108614 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Jiedan Liao und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Animal Science and Technology, Foshan University, Guangdong, 528225, China; Foshan University Veterinary Teaching Hospital, Foshan Universi…. Hauptthemen laut MEDLINE: Lignans, Biphenyl Compounds, Streptococcus suis, Streptococcal Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Science and Technology Planning Project of Guangdong Province, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus suis serotype 2 (SS2) is a highly virulent zoonotic pathogen that causes substantial economic losses in the swine industry and poses a serious threat to public health. Magnolol, a key bioactive compound derived from Magnolia officinalis, is known for its anti-inflammatory and antibacterial properties, yet its specific impact on SS2-induced inflammatory injury has not been fully elucidated. This study aimed to elucidate the protective mechanisms of magnolol against SS2 infection. We initially demonstrated that SS2 infection induces severe pulmonary inflammation in mice, characterized by alveolar wall thickening, tissue congestion, and increased secretion of the pro-inflammatory cytokines IL-1β and IL-18. Treatment with magnolol significantly alleviated these pathological changes, reduced lung tissue damage, and decreased cytokine release. In vitro experiments further revealed that magnolol attenuated SS2-induced macrophage membrane disruption, as indicated by decreased propidium iodide (PI) uptake, and inhibited the production of IL-1β and IL-18. Mechanistic investigations using Western blot analysis confirmed that magnolol reduced the expression of GSDMD. Correspondingly, GSDMD-deficient mice exhibited reduced bacterial loads in multiple tissues, diminished lung inflammation, downregulated expression of IL-1β and IL-18, enhanced macrophage recruitment, and decreased macrophage death-effects that closely mirrored those achieved with magnolol treatment. Collectively, these findings demonstrate that magnolol alleviates SS2-induced inflammatory injury by inhibiting GSDMD, underscoring its potential as a host-directed therapeutic agent for the management of streptococcal infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansBiphenyl CompoundsStreptococcus suisStreptococcal InfectionsPhosphate-Binding ProteinsPneumoniaAnimalsMiceLungInterleukin-1betaDisease Models, AnimalMacrophagesCytokinesBacterial LoadInterleukin-18Anti-Inflammatory AgentsMice, Inbred C57BLMale

Stichwörter der Autor:innen

GSDMDMacrophageMagnololPulmonary inflammationStreptococcus suis type 2

Substanzen

LignansBiphenyl CompoundsmagnololInterleukin-1betaCytokinesInterleukin-18Phosphate-Binding ProteinsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Animal Science and Technology, Foshan University, Guangdong, 528225, China; Foshan University Veterinary Teaching Hospital, Foshan University, Guangdong, 528225, China.
  • School of Animal Science and Technology, Foshan University, Guangdong, 528225, China; Foshan University Veterinary Teaching Hospital, Foshan University, Guangdong, 528225, China. Electronic address: fuqiang@fosu.edu.cn.

Förderung

  • Science and Technology Planning Project of Guangdong Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Department of Education of Guangdong Province
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Zitieren

APA

Liao, J., Xiu, Y., Su, R., Wu, Z., Deng, Z., Xie, H., Zhan, X., Li, Y., Sun, Q., Huang, Y., & Fu, Q. (2026). Magnolol ameliorates Streptococcus suis serotype 2-induced pulmonary inflammatory injury in mice via inhibition of GSDMD. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108614

Vancouver

Liao J, Xiu Y, Su R, Wu Z, Deng Z, Xie H, et al. Magnolol ameliorates Streptococcus suis serotype 2-induced pulmonary inflammatory injury in mice via inhibition of GSDMD. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108614

BibTeX
@article{Liao2026,
  author = {Liao, Jiedan and Xiu, Yixin and Su, Rouna and Wu, Zhaoru and Deng, Ziteng and Xie, Honglin and Zhan, Xiaoshu and Li, Yajuan and Sun, Qinqin and Huang, Yunfei and Fu, Qiang},
  title = {Magnolol ameliorates Streptococcus suis serotype 2-induced pulmonary inflammatory injury in mice via inhibition of GSDMD},
  journal = {Microbial Pathogenesis},
  year = {2026},
  doi = {10.1016/j.micpath.2026.108614}
}
Kostenlos starten →